Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Paradoxical effect of high and low dose aspirin in experimental arterial thrombosis.

Zimmermann R, Thiessen M, Walter E, Mörl H.

Artery. 1980;8(5):422-5.

PMID:
7213048
[PubMed - indexed for MEDLINE]
2.

The paradoxical thrombogenic effect of aspirin in experimental thrombosis.

Zimmerman R, Thiessen M, Mörl H, Weckesser G.

Thromb Res. 1979;16(5-6):843-6. No abstract available.

PMID:
392806
[PubMed - indexed for MEDLINE]
3.

Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.

Wong PC, Crain EJ, Watson CA, Wexler RR, Lam PY, Quan ML, Knabb RM.

J Thromb Thrombolysis. 2007 Aug;24(1):43-51. Epub 2007 Feb 24.

PMID:
17323133
[PubMed - indexed for MEDLINE]
4.

The differential effects of aspirin on platelets, leucocytes and vascular endothelium in an in vivo model of thrombus formation.

Nagamatsu Y, Tsujioka Y, Hashimoto M, Giddings JC, Yamamoto J.

Clin Lab Haematol. 1999 Feb;21(1):33-40.

PMID:
10197261
[PubMed - indexed for MEDLINE]
5.

The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.

McClanahan TB, Hicks GW, Morrison AL, Peng YW, Janiczek-Dolphin N, Mertz TE, Sullivan ME, Morser J, Juneau PL, Leadley R.

Eur J Pharmacol. 2001 Dec 7;432(2-3):187-94.

PMID:
11740955
[PubMed - indexed for MEDLINE]
6.

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans.

Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B.

Circulation. 2000 Jun 20;101(24):2823-8.

PMID:
10859288
[PubMed - indexed for MEDLINE]
Free Article
7.

Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat.

Daykin HJ, Sturgeon SA, Jones C, Wright CE.

Thromb Res. 2006;118(6):755-62. Epub 2006 Jan 10.

PMID:
16410020
[PubMed - indexed for MEDLINE]
8.

Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.

Lyman BT, Johnson GJ, White JG.

Am J Pathol. 1978 Aug;92(2):473-90.

PMID:
677271
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.

Wåhlander K, Eriksson-Lepkowska M, Nyström P, Eriksson UG, Sarich TC, Badimon JJ, Kalies I, Elg M, Bylock A.

Thromb Haemost. 2006 Mar;95(3):447-53.

PMID:
16525572
[PubMed - indexed for MEDLINE]
10.

Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.

Bossavy JP, Sakariassen KS, Thalamas C, Boneu B, Cadroy Y.

Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2269-75.

PMID:
10479672
[PubMed - indexed for MEDLINE]
Free Article
11.

Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.

Valentin JP, Vieu S, Bertolino F, Fauré P, John GW.

J Pharmacol Exp Ther. 1997 Feb;280(2):761-9.

PMID:
9023289
[PubMed - indexed for MEDLINE]
Free Article
12.

Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis.

Schumacher WA, Heran CL, Youssef S, Megill JR, Michel I, Durham SK.

Haemostasis. 1993 Jul-Aug;23(4):219-28.

PMID:
8314172
[PubMed - indexed for MEDLINE]
13.
14.

Correlation between bleeding time and antithrombotic effect of platelet-suppressive agents in rat experimental model.

Suehiro A, Oura Y, Ueda M, Kakishita E.

Res Commun Chem Pathol Pharmacol. 1994 Feb;83(2):157-63.

PMID:
8202629
[PubMed - indexed for MEDLINE]
15.

Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbits.

Wong PC, Watson CA, Crain EJ.

J Thromb Haemost. 2008 Oct;6(10):1736-41. doi: 10.1111/j.1538-7836.2008.03092.x. Epub 2008 Jul 19.

PMID:
18647224
[PubMed - indexed for MEDLINE]
16.

Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis.

Schumacher WA, Heran CL, Steinbacher TE, Youssef S, Ogletree ML.

J Cardiovasc Pharmacol. 1993 Oct;22(4):526-33.

PMID:
7505353
[PubMed - indexed for MEDLINE]
17.

Sex differences in the antithrombotic effects of aspirin.

Kelton JG, Hirsh J, Carter CJ, Buchanan MR.

Blood. 1978 Nov;52(5):1073-6.

PMID:
698392
[PubMed - indexed for MEDLINE]
Free Article
18.

Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.

Karnicki K, Leadley RJ Jr, Baxi S, Peterson T, Wysokinski W, McBane RD 2nd.

Thromb Haemost. 2008 Apr;99(4):759-66. doi: 10.1160/TH07-09-0576.

PMID:
18392334
[PubMed - indexed for MEDLINE]
19.

Failure of aspirin at different doses to modify experimental thrombosis in rats.

Reyers I, Mussoni L, Donati MB, de Gaetano G.

Thromb Res. 1980 Jun 1;18(5):669-74. No abstract available.

PMID:
7414553
[PubMed - indexed for MEDLINE]
20.

[Experimental evaluation of low-dose aspirin used in microvascular surgery].

An ZQ, Gu YD, Zhong GR.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2000 May;14(3):145-8. Chinese.

PMID:
12080850
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk